Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000919574-25-001049·OptimizeRx Corp
Schedule 13G ownership disclosure
OptimizeRx Corp
Common Stock, par value $0.001 · CUSIP: 68401U204
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- SAMJO MANAGEMENT, LLC
Shares: 50.00 · Class: 0.0%
- ANDREW N. WIENER
Shares: 50.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-001049
- Form type
- SCHEDULE 13G/A
- Filer
- OptimizeRx Corp
- CIK
- CIK 1448431
- Filed
- Feb 13, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership